CD4 and systemic sclerosis: The number of IFNγ- and IL-4-producing CD4+ T cells in SSc patients was significantly higher than in normal controls (21.1% vs. 12.5% for IFN-γ, Figure 7B; 15% vs. 7.1% for IL-4, Figure 7C; P <0.05).